Navigation Links
Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes

12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action Sitagliptin is a DPP-4 inhibitor, which is believed to exert its actions in patients with type 2 diabetes by slowing the inactivation of incretin hormones. Concentrations of the active intact hormones are increased by JANUVIA, thereby increasing and prolonging the action of these hormones. Incretin hormones, including glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), are released by the intestine throughout the day, and levels are increased in response to a meal. These hormones are rapidly inactivated by the enzyme, DPP-4. The incretins are part of an endogenous system involved in the physiologic regulation of glucose homeostasis. When blood glucose concentrations are normal or elevated, GLP-1 and GIP increase insulin synthesis and release from pancreatic beta cells by intracellular signaling pathways involving cyclic AMP. GLP-1 also lowers glucagon secretion from pancreatic alpha cells, leading to reduced hepatic glucose production. By increasing and prolonging active incretin levels, JANUVIA increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. Sitagliptin demonstrates selectivity for DPP-4 and does not inhibit DPP-8 or DPP-9 activity in vitro at concentrations approximating those from therapeutic doses. 12.2 Pharmacodynamics General In patients with type 2 diabetes, administration of JANUVIA led to inhibition of DPP-4 enzyme activity for a 24-hour period. After an oral glucose load or a meal, this DPP-4 inhibition resulted in a 2- to 3-fold increase in circulating levels of active GLP-1 and GIP, decreased glucagon concentrations, and increased responsiveness of insulin release to glucose, resulting in higher C-peptide and insulin concentrations. The rise in insulin with the decrease in glucagon was associated with lower fasting glucose concentrations and reduced gluc
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
2. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
3. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
4. Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions
5. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
6. Everest Data on Short- and Long-Term Use of Otsukas Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACCs Late Breaking Clinical Trials
7. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
8. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
9. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
10. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
11. New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting
Post Your Comments:
(Date:7/30/2014)... 30, 2014  Today the US Surgeon General issued the ... tanning or sun burns stating they can lead directly to ... Boris Lushniak , says that "skin cancer is a major ... much exposure to indoor and outdoor ultraviolet light is a ... Medicine, in Boca Raton, Florida , ...
(Date:7/30/2014)... Reportlinker.com announces that a new market ... mHealth and Home Monitoring – 6th Edition ... Executive summary mHealth can revolutionize how ... decreased costs and improved sustainability of the healthcare ... in an early stage, but on the brink ...
(Date:7/30/2014)... N.J. , July 30, 2014 Stryker brand ambassadors ... this week at the 3M Championship Champions Tour event near ... Cities, in Blaine . Stryker is the official ... Starting Friday, August 1 st through Sunday, ... Stryker Mobility Zone; an on-site joint health destination located in the ...
Breaking Medicine Technology:Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer 2mHealth and Home Monitoring - 6th Edition 2mHealth and Home Monitoring - 6th Edition 3mHealth and Home Monitoring - 6th Edition 4mHealth and Home Monitoring - 6th Edition 5mHealth and Home Monitoring - 6th Edition 6mHealth and Home Monitoring - 6th Edition 7mHealth and Home Monitoring - 6th Edition 8mHealth and Home Monitoring - 6th Edition 9mHealth and Home Monitoring - 6th Edition 10mHealth and Home Monitoring - 6th Edition 11Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 3Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 4Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 5
... Masimo (NASDAQ: MASI ) announced today ... for the period ended December 31, 2011, after the market closes ... will begin at 1:30 p.m. PT (4:30 p.m. ET) and will ... Mark P. de Raad, Executive Vice President and Chief Financial Officer. ...
... NEW YORK, Jan. 26, 2012 Dr. Ira J. Haimowitz, ... CementBloc, will be a featured presenter at the eMarketing University ... New York City on February 6, 2012. The ... product management seeking to incorporate digital tactics into their marketing ...
Cached Medicine Technology:Masimo to Report Fourth Quarter and Full Year 2011 Financial Results After Market Close on February 14, 2012 2Masimo to Report Fourth Quarter and Full Year 2011 Financial Results After Market Close on February 14, 2012 3Ira Haimowitz, PhD, EVP, at The CementBloc, to Present on Best Practices in iPad Interactive Selling at 11th Annual ePharma Summit™ 2
(Date:7/31/2014)... Nashville, TN (PRWEB) July 31, 2014 ... a pipeline partner with the National Rural Health Association ... commitment by ProtonPACS to understanding the needs of rural ... with the National Rural Health Association,” said Dr. Mark ... share the many advantages of ProtonPACS, we are also ...
(Date:7/31/2014)... 2014) While it is known that members of the ... a new study finds that female enlistees and female ... civilian counterparts. This study was published today in ... on behalf of the Inter-University Seminar on Armed Forces ... Tedrow studied surveys of nearly 9,000 men and women ...
(Date:7/31/2014)... Staying happy in a relationship and loving for years ... get sucked into the logistical ruts they know as their ... kids. , That’s why Couples in Trouble Relationship Expert, ... to Reignite the Spark in Your Marriage TODAY” Guide as ... much better path to happiness, and a far less costly ...
(Date:7/31/2014)... According to new research report "Meat Substitutes ... (Tofu, Tofu-Based Product, Tempeh, TVP, Seitan, Quorn, Others), ... Forecasts to 2019", defines and segments the global ... of the market value of sources, types, and ... the driving and restraining factors for the global ...
(Date:7/31/2014)... Eden Lew has been awarded the ... Technologies" Scholarship through EDSF (Electronic Document ... the contributions Chuck Forman made throughout his career ... his battle with cancer on October 2, 2013. ... thrilled to see her receive the second annual ...
Breaking Medicine News(10 mins):Health News:ProtonPACS Announces Pipeline Partnership with the National Rural Health Association. 2Health News:Women in military less likely to drink than civilian women 2Health News:Couples in Trouble Relationship Expert, Dr. Jackie Black, Offers a Gift Guide to Reignite the Spark So Lovers Can Kiss-And-Make-Up 2Health News:Couples in Trouble Relationship Expert, Dr. Jackie Black, Offers a Gift Guide to Reignite the Spark So Lovers Can Kiss-And-Make-Up 3Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 2Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 3Health News:Eden Lew Recipient of 2014 EDSF Scholarship Honoring Chuck Forman 2Health News:Eden Lew Recipient of 2014 EDSF Scholarship Honoring Chuck Forman 3
... Consumer protection group,s new resource helps Americans cut prescription ... , WASHINGTON, Dec. 1 A collection ... to consumers to help fend off the dangers of ... Partnership for Safe Medicines, "Consumer Resources" is designed to ...
... Indicated for the Treatment of Both Moderate to Severe Vaginal Dryness ... Due to Menopause , , ... , MONTVALE, N.J., Dec. 1 Barr ... U.S. Food and Drug Administration (FDA) has approved its subsidiary Duramed ...
... found in disorder, study says , , MONDAY, Dec. ... process sounds a fraction of a second slower than ... and language issues linked to the condition, a new ... which records minute magnetic fields associated with electrical brain ...
... lesson from 2 failed trials: The science must be more vigorous, ... HIV would give up without a fight. , As World AIDS ... at what went wrong in recent, high-profile failures of two human ... is still very possible, and with it comes the ...
... Decision Resources, one of the,world,s leading research and advisory ... share for GlaxoSmithKline,s Advair is,declining in all lines of ... The new report entitled Treatment ... first-, second- and third-lines of therapy to 12.2 percent,13.6 ...
... the international generic pharmaceuticals company, today announced that it ... Administration to market Bupropion Hydrochloride extended-release tablets (XL) 150mg. ... , , Bupropion Hydrochloride ... are the generic equivalent of Wellbutrin XL(R) for the ...
Cached Medicine News:Health News:Partnership for Safe Medicines Arms Public Against Counterfeit Drugs 2Health News:Partnership for Safe Medicines Arms Public Against Counterfeit Drugs 3Health News:Partnership for Safe Medicines Arms Public Against Counterfeit Drugs 4Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 2Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 3Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 4Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 5Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 6Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 7Health News:Scans Show Sound-Processing Deficits in Autistic Kids 2Health News:Hopes for AIDS Vaccine Still Alive Despite Setbacks 2Health News:Hopes for AIDS Vaccine Still Alive Despite Setbacks 3Health News:Hopes for AIDS Vaccine Still Alive Despite Setbacks 4Health News:Advair's Patient Share in Newly Diagnosed Asthma Patients is Declining 2Health News:Actavis Receives Approval of Generic Wellbutrin XL(R) 150mg in the U.S. 2
The Prostar XL 8 is a suture mediated closure system. It can be used with 8F sheath. It has two 3-0 braided polyester sutures and also has the safety of guidewire....
... vascular closure device quickly seals ... procedures, allowing for early ambulation ... creates a mechanical seal by ... bio-absorbable anchor and collagen sponge, ...
Terumo's Optitorque offers superior torque and precision control. It's patient-friendly, high torque design makes it the catheter of choice for demanding angiography....
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Medicine Products: